Stephen Garbacz

Corporate Officer/Principal bei Tessera Therapeutics, Inc.

65 Jahre

Health Technology

Consumer Services

Aktive Positionen von Stephen Garbacz

Unternehmen	Position	Beginn	Ende
Tessera Therapeutics, Inc. Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA.	Corporate Officer/Principal	01.05.2021	-

Unternehmen	Position	Beginn	Ende
ANIKA THERAPEUTICS, INC.	Comptroller/Controller/Auditor	06.05.2019	01.05.2021
SPERO THERAPEUTICS, INC.	Geschäftsführer	01.01.2015	-
SPERO THERAPEUTICS, INC.	Corporate Officer/Principal	01.01.2015	-
EPIZYME, INC.	Comptroller/Controller/Auditor	01.10.2014	09.02.2015
EPIZYME, INC.	Finanzdirektor/CFO	01.08.2012	-

The Leonard N Stern School of Business	Masters Business Admin
George Mason University	Undergraduate Degree

International

Vereinigte Staaten

Operativ

Comptroller/Controller/Auditor	2
Corporate Officer/Principal	2
Director of Finance/CFO	1

Sektoral

Health Technology	5
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
SPERO THERAPEUTICS, INC.	Health Technology
ANIKA THERAPEUTICS, INC.	Health Technology

Private Unternehmen	2
Epizyme, Inc. Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA.	Health Technology
Tessera Therapeutics, Inc. Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA.	Health Technology

Private Unternehmen

Health Technology